User menu

Accès à distance ? S'identifier sur le proxy UCLouvain | Saint-Louis

An individualized radiation dose escalation trial in non-small cell lung cancer based on FDG-PET imaging.

  1. Aupérin Anne, Le Péchoux Cecile, Rolland Estelle, Curran Walter J., Furuse Kiyoyuki, Fournel Pierre, Belderbos Jose, Clamon Gerald, Ulutin Hakki Cuneyt, Paulus Rebecca, Yamanaka Takeharu, Bozonnat Marie-Cecile, Uitterhoeve Apollonia, Wang Xiaofei, Stewart Lesley, Arriagada Rodrigo, Burdett Sarah, Pignon Jean-Pierre, Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer, 10.1200/jco.2009.26.2543
  2. Palma David, Visser Otto, Lagerwaard Frank J., Belderbos Jose, Slotman Ben J., Senan Suresh, Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis, 10.1200/jco.2010.30.0731
  3. Belderbos Jose S.A., Heemsbergen Wilma D., De Jaeger Katrien, Baas Paul, Lebesque Joos V., Final results of a Phase I/II dose escalation trial in non–small-cell lung cancer using three-dimensional conformal radiotherapy, 10.1016/j.ijrobp.2006.04.034
  4. Bentzen S.M., Saunders M.I., Dische S., From CHART to CHARTWEL in Non-small Cell Lung Cancer: Clinical Radiobiological Modelling of the Expected Change in Outcome, 10.1053/clon.2002.0117
  5. Kong Feng-Ming, Ten Haken Randall K., Schipper Matthew J., Sullivan Molly A., Chen Ming, Lopez Carlos, Kalemkerian Gregory P., Hayman James A., High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non–small-cell lung cancer: Long-term results of a radiation dose escalation study, 10.1016/j.ijrobp.2005.02.010
  6. Machtay Mitchell, Bae Kyounghwa, Movsas Benjamin, Paulus Rebecca, Gore Elizabeth M., Komaki Ritsuko, Albain Kathy, Sause William T., Curran Walter J., Higher Biologically Effective Dose of Radiotherapy Is Associated With Improved Outcomes for Locally Advanced Non–Small Cell Lung Carcinoma Treated With Chemoradiation: An Analysis of the Radiation Therapy Oncology Group, 10.1016/j.ijrobp.2010.09.004
  7. Saunders M.I., Rojas A., Lyn B.E., Wilson E., Phillips H., Dose-escalation with CHARTWEL (Continuous Hyperfractionated Accelerated Radiotherapy Week-End Less) Combined with Neo-adjuvant Chemotherapy in the Treatment of Locally Advanced Non-small Cell Lung Cancer, 10.1053/clon.2002.0121
  8. Bradley Jeffrey D, Paulus Rebecca, Komaki Ritsuko, Masters Gregory, Blumenschein George, Schild Steven, Bogart Jeffrey, Hu Chen, Forster Kenneth, Magliocco Anthony, Kavadi Vivek, Garces Yolanda I, Narayan Samir, Iyengar Puneeth, Robinson Cliff, Wynn Raymond B, Koprowski Christopher, Meng Joanne, Beitler Jonathan, Gaur Rakesh, Curran Walter, Choy Hak, Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study, 10.1016/s1470-2045(14)71207-0
  9. Hoffmann Aswin L., Troost Esther G.C., Huizenga Henk, Kaanders Johannes H.A.M., Bussink Johan, Individualized Dose Prescription for Hypofractionation in Advanced Non-Small-Cell Lung Cancer Radiotherapy: An in silico Trial, 10.1016/j.ijrobp.2011.10.032
  10. Mehta Minesh, Scrimger Rufus, Mackie Rock, Paliwal Bhudatt, Chappell Rick, Fowler Jack, A new approach to dose escalation in non–small-cell lung cancer, 10.1016/s0360-3016(00)01374-2
  11. Cox James D., Are the Results of RTOG 0617 Mysterious?, 10.1016/j.ijrobp.2011.12.032
  12. Wanet Marie, Lee John Aldo, Weynand Birgit, De Bast Marc, Poncelet Alain, Lacroix Valérie, Coche Emmanuel, Grégoire Vincent, Geets Xavier, Gradient-based delineation of the primary GTV on FDG-PET in non-small cell lung cancer: A comparison with threshold-based approaches, CT and surgical specimens, 10.1016/j.radonc.2010.10.006
  13. Aerts Hugo J.W.L., Bosmans Geert, van Baardwijk Angela A.W., Dekker Andre L.A.J., Oellers Michel C., Lambin Philippe, De Ruysscher Dirk, Stability of 18F-Deoxyglucose Uptake Locations Within Tumor During Radiotherapy for NSCLC: A Prospective Study, 10.1016/j.ijrobp.2007.11.049
  14. Aerts Hugo J.W.L., Bussink Johan, Oyen Wim J.G., van Elmpt Wouter, Folgering Annemieke M., Emans Daisy, Velders Marije, Lambin Philippe, De Ruysscher Dirk, Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: A prospective validation, 10.1016/j.lungcan.2011.06.003
  15. Borst Gerben R., Belderbos José S.A., Boellaard Ronald, Comans Emile F.I., Jaeger Katrien De, Lammertsma Adriaan A., Lebesque Joos V., Standardised FDG uptake: A prognostic factor for inoperable non-small cell lung cancer, 10.1016/j.ejca.2005.03.026
  16. Petit Steven F., Aerts Hugo J.W.L., van Loon Judith G.M., Offermann Claudia, Houben Ruud, Winkens Bjorn, Öllers Michel C., Lambin Philippe, De Ruysscher Dirk, Dekker André L.A.J., Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): An exploratory clinical study, 10.1016/j.radonc.2009.02.020
  17. van Baardwijk Angela, Bosmans Geert, Dekker André, van Kroonenburgh Marinus, Boersma Liesbeth, Wanders Stofferinus, Öllers Michel, Houben Ruud, Minken André, Lambin Philippe, De Ruysscher Dirk, Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients, 10.1016/j.radonc.2007.01.007
  18. Velazquez Emmanuel Rios, Aerts Hugo J. W. L., Oberije Cary, De Ruysscher Dirk, Lambin Philippe, Prediction of residual metabolic activity after treatment in NSCLC patients, 10.3109/0284186x.2010.498441
  19. Medicine University of Wisconsin School of, , 10.1016/s0360-3016(99)00364-8
  20. Machtay Mitchell, Hsu Chuanchieh, Komaki Ritsuko, Sause William T., Swann R. Suzanne, Langer Corey J., Byhardt Roger W., Curran Walter J., Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non–small-cell lung carcinoma: Analysis of the Radiation Therapy Oncology Group (RTOG) experience, 10.1016/j.ijrobp.2005.03.037
  21. van Baardwijk Angela, Bosmans Geert, Bentzen Søren M., Boersma Liesbeth, Dekker André, Wanders Rinus, Wouters Bradly G., Lambin Philippe, De Ruysscher Dirk, Radiation Dose Prescription for Non–Small-Cell Lung Cancer According to Normal Tissue Dose Constraints: An In Silico Clinical Trial, 10.1016/j.ijrobp.2007.11.028
  22. van Baardwijk Angela, Reymen Bart, Wanders Stofferinus, Borger Jacques, Öllers Michel, Dingemans Anne-Marie C., Bootsma Gerben, Geraedts Wiel, Pitz Cordula, Lunde Ragnar, Peters Frank, Lambin Philippe, Ruysscher Dirk De, Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer, 10.1016/j.ejca.2012.04.014
  23. Schwarz Marco, Alber Markus, Lebesque Joos V., Mijnheer Ben J., Damen Eugène M.F., Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non–small-cell lung cancer, 10.1016/j.ijrobp.2005.02.011
  24. Goossens Samuel, Senny Frédéric, Lee John Aldo, Janssens Guillaume, Geets Xavier, Assessment of tumor motion reproducibility with audio-visual coaching through successive 4D CT sessions, 10.1120/jacmp.v15i1.4332
  25. Sterpin Edmond, Janssens Guillaume, Orban de Xivry Jonathan, Goossens Samuel, Wanet Marie, Lee John A., Delor Antoine, Bol Vanesa, Vynckier Stefaan, Gregoire Vincent, Geets Xavier, Helical tomotherapy for SIB and hypo-fractionated treatments in lung carcinomas: A 4D Monte Carlo treatment planning study, 10.1016/j.radonc.2012.06.005
  26. Geets Xavier, Lee John A., Bol Anne, Lonneux Max, Grégoire Vincent, A gradient-based method for segmenting FDG-PET images: methodology and validation, 10.1007/s00259-006-0363-4
  27. Bradley Jeffrey, Graham Mary V., Winter Kathryn, Purdy James A., Komaki Ritsuko, Roa Wilson H., Ryu Janice K., Bosch Walter, Emami Bahman, Toxicity and outcome results of RTOG 9311: A phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non–small-cell lung carcinoma, 10.1016/j.ijrobp.2004.06.260
  28. Bradley Jeffrey D., Moughan Jennifer, Graham Mary V., Byhardt Roger, Govindan Ramaswamy, Fowler Jack, Purdy James A., Michalski Jeff M., Gore Elizabeth, Choy Hak, A Phase I/II Radiation Dose Escalation Study With Concurrent Chemotherapy for Patients With Inoperable Stages I to III Non-Small-Cell Lung Cancer: Phase I Results of RTOG 0117, 10.1016/j.ijrobp.2009.04.029
  29. Gagliardi Giovanna, Constine Louis S., Moiseenko Vitali, Correa Candace, Pierce Lori J., Allen Aaron M., Marks Lawrence B., Radiation Dose–Volume Effects in the Heart, 10.1016/j.ijrobp.2009.04.093
  30. Marks Lawrence B., Bentzen Soren M., Deasy Joseph O., Kong Feng-Ming (Spring), Bradley Jeffrey D., Vogelius Ivan S., El Naqa Issam, Hubbs Jessica L., Lebesque Joos V., Timmerman Robert D., Martel Mary K., Jackson Andrew, Radiation Dose–Volume Effects in the Lung, 10.1016/j.ijrobp.2009.06.091
  31. Shi Anhui, Zhu Guangying, Wu Hao, Yu Rong, Li Fuhai, Xu Bo, Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy, 10.1186/1748-717x-5-35
  32. Song Chang Hoon, Pyo Hongryull, Moon Sung Ho, Kim Tae Hyun, Kim Dae Woong, Cho Kwan Ho, Treatment-Related Pneumonitis and Acute Esophagitis in Non–Small-Cell Lung Cancer Patients Treated With Chemotherapy and Helical Tomotherapy, 10.1016/j.ijrobp.2009.08.068
  33. van Baardwijk Angela, Wanders Stofferinus, Boersma Liesbeth, Borger Jacques, Öllers Michel, Dingemans Anne-Marie C., Bootsma Gerben, Geraedts Wiel, Pitz Cordula, Lunde Ragnar, Lambin Philippe, De Ruysscher Dirk, Mature Results of an Individualized Radiation Dose Prescription Study Based on Normal Tissue Constraints in Stages I to III Non–Small-Cell Lung Cancer, 10.1200/jco.2009.24.7221
  34. van Elmpt Wouter, De Ruysscher Dirk, van der Salm Anke, Lakeman Annemarie, van der Stoep Judith, Emans Daisy, Damen Eugène, Öllers Michel, Sonke Jan-Jakob, Belderbos José, The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer, 10.1016/j.radonc.2012.03.005
  35. Werner-Wasik Maria, Yorke Ellen, Deasy Joseph, Nam Jiho, Marks Lawrence B., Radiation Dose-Volume Effects in the Esophagus, 10.1016/j.ijrobp.2009.05.070
  36. Socinski Mark A., Morris David E., Halle Jan S., Moore Dominic T., Hensing Thomas A., Limentani Steven A., Fraser Robert, Tynan Maureen, Mears Andrea, Rivera M. Patricia, Detterbeck Frank C., Rosenman Julian G., Induction and Concurrent Chemotherapy With High-Dose Thoracic Conformal Radiation Therapy in Unresectable Stage IIIA and IIIB Non–Small-Cell Lung Cancer: A Dose-Escalation Phase I Trial, 10.1200/jco.2004.03.022
  37. Wahl R. L., Jacene H., Kasamon Y., Lodge M. A., From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors, 10.2967/jnumed.108.057307
  38. Skougaard K., Nielsen D., Jensen B. V., Hendel H. W., Comparison of EORTC Criteria and PERCIST for PET/CT Response Evaluation of Patients with Metastatic Colorectal Cancer Treated with Irinotecan and Cetuximab, 10.2967/jnumed.112.111757
  39. Eisenhauer E.A., Therasse P., Bogaerts J., Schwartz L.H., Sargent D., Ford R., Dancey J., Arbuck S., Gwyther S., Mooney M., Rubinstein L., Shankar L., Dodd L., Kaplan R., Lacombe D., Verweij J., New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1), 10.1016/j.ejca.2008.10.026
  40. Young H., Baum R., Cremerius U., Herholz K., Hoekstra O., Lammertsma A.A., Pruim J., Price P., Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations, 10.1016/s0959-8049(99)00229-4
  41. De Ruysscher Dirk, Wanders Stofferinus, van Haren Erik, Hochstenbag Monique, Geeraedts Wiel, Utama Irwan, Simons Jean, Dohmen Jo, Rhami Ali, Buell Ulrich, Thimister Paul, Snoep Gabriel, Boersma Liesbeth, Verschueren Tom, van Baardwijk Angela, Minken Andre, Bentzen Søren M., Lambin Philippe, Selective mediastinal node irradiation based on FDG-PET scan data in patients with non–small-cell lung cancer: A prospective clinical study, 10.1016/j.ijrobp.2004.12.019
  42. Bradley Jeffrey D, Wahab Sasha, Lockett Mary Ann, Perez Carlos A, Purdy James A, Elective nodal failures are uncommon in medically inoperable patients with Stage I non–small-cell lung carcinoma treated with limited radiotherapy fields, 10.1016/s0360-3016(02)04614-x
  43. Emami Bahman, Mirkovic Nena, Scott Charles, Byhardt Roger, Graham Mary V., James Andras E., John Madhu, Herskovic Arnold, Urtasun Raul, Asbell Sucha O., Perez Carlos A., Cox James, The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data, 10.1016/s0169-5002(03)00228-9
  44. Garg Shalini, Gielda Benjamin T., Turian Julius V., Liptay Michael, Warren William H., Bonomi Philip, Sher David J., Patterns of regional failure in stage III non-small cell lung cancer treated with neoadjuvant chemoradiation therapy and resection, 10.1016/j.prro.2012.09.002
  45. Rosenzweig Kenneth E, Sim Sang E, Mychalczak Borys, Braban Louise E, Schindelheim Rachel, Leibel Steven A, Elective nodal irradiation in the treatment of non–small-cell lung cancer with three-dimensional conformal radiation therapy, 10.1016/s0360-3016(01)01482-1
  46. Senan Suresh, Burgers Sjaak, Samson Michael J, van Klaveren Rob J, Oei Swie Swat, van Sörnsen de Koste John, Voet Peter W.J, Lagerwaard Frank J, Maarten van Haarst Jan, Aerts Joachim G.J.V, van Meerbeeck Jan P, Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy, 10.1016/s0360-3016(02)03028-6
  47. Provencio Mariano, Sánchez Antonio, Garrido Pilar, Valcárcel Francisco, New Molecular Targeted Therapies Integrated With Radiation Therapy in Lung Cancer, 10.3816/clc.2010.n.012
  48. Zhuang HongQing, zhao lujun, wang ping, Pang Qinsong, Zhao Xianzhi, Progress of clinical research on targeted therapy combined with thoracic radiotherapy for non-small-cell lung cancer, 10.2147/dddt.s61977
  49. Han Cheng-Bo, Wang Wei-Li, Quint Leslie, Xue Jian-Xin, Matuszak Martha, Ten Haken Randall, Kong Feng-Ming (Spring), Pulmonary Artery Invasion, High-Dose Radiation, and Overall Survival in Patients With Non-Small Cell Lung Cancer, 10.1016/j.ijrobp.2014.02.011
  50. Cannon Donald M., Mehta Minesh P., Adkison Jarrod B., Khuntia Deepak, Traynor Anne M., Tomé Wolfgang A., Chappell Richard J., Tolakanahalli Ranjini, Mohindra Pranshu, Bentzen Søren M., Cannon George M., Dose-Limiting Toxicity After Hypofractionated Dose-Escalated Radiotherapy in Non–Small-Cell Lung Cancer, 10.1200/jco.2013.51.5353
  51. Timmerman Robert, McGarry Ronald, Yiannoutsos Constantin, Papiez Lech, Tudor Kathy, DeLuca Jill, Ewing Marvene, Abdulrahman Ramzi, DesRosiers Colleen, Williams Mark, Fletcher James, Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer, 10.1200/jco.2006.07.5937
  52. Langendijk Johannes A., Tjwa Martin K.T., de Jong Jos M.A., ten Velde Guul P.M., Wouters Emiel F.M., Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor?, 10.1016/s0167-8140(98)00103-0
  53. Wanet Marie, Sterpin Edmond, Janssens Guillaume, Delor Antoine, Lee John Aldo, Geets Xavier, Validation of the mid-position strategy for lung tumors in helical TomoTherapy, 10.1016/j.radonc.2013.10.025
Bibliographic reference Wanet, Marie ; Delor, Antoine ; Hanin, François-Xavier ; Ghaye, Benoît ; Van Maanen, Aline ; et. al. An individualized radiation dose escalation trial in non-small cell lung cancer based on FDG-PET imaging.. In: Strahlentherapie und Onkologie, Vol. 193, no. 10, p. 812-822 (2017)
Permanent URL